This analysis failed to identify additional or sub-clonal SF3B1 mutations in the 16 papillary carcinomas that had been shown be SF3B1 wild-type by Sanger sequencing analysis. This evidence concerns the gene SF3B1 and thyroid gland papillary carcinoma.